Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension

  • Paul L. Kaufman
  • Expert Opinion on Pharmacotherapy, February 2017, Taylor & Francis
  • DOI: 10.1080/14656566.2017.1293654

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14656566.2017.1293654